184 related articles for article (PubMed ID: 18204417)
1. Open-label, concomitant use of lamotrigine and other medications for bipolar disorder.
Bowden CL; Edwards S; Evoniuk G
CNS Spectr; 2008 Jan; 13(1):75-83. PubMed ID: 18204417
[TBL] [Abstract][Full Text] [Related]
2. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
[TBL] [Abstract][Full Text] [Related]
3. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
[TBL] [Abstract][Full Text] [Related]
4. Combining lithium and anticonvulsants in bipolar disorder: a review.
Pies R
Ann Clin Psychiatry; 2002 Dec; 14(4):223-32. PubMed ID: 12630658
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression.
Ahn YM; Nam JY; Culver JL; Marsh WK; Bonner JC; Ketter TA
Ann Clin Psychiatry; 2011 Feb; 23(1):17-24. PubMed ID: 21318192
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode: A Post Hoc Analysis of 2 Placebo-Controlled Trials.
Tocco M; Mao Y
J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):345-352. PubMed ID: 38639433
[TBL] [Abstract][Full Text] [Related]
8. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
Yatham LN; Fallu A; Binder CE
Acta Psychiatr Scand Suppl; 2007; (434):50-6. PubMed ID: 17688463
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
Redmond JR; Jamison KL; Bowden CL
CNS Spectr; 2006 Dec; 11(12):915-8. PubMed ID: 17146405
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.
Calabrese JR; Bowden CL; McElroy SL; Cookson J; Andersen J; Keck PE; Rhodes L; Bolden-Watson C; Zhou J; Ascher JA
Am J Psychiatry; 1999 Jul; 156(7):1019-23. PubMed ID: 10401445
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
Wang Z; Gao K; Kemp DE; Chan PK; Serrano MB; Conroy C; Fang Y; Ganocy SJ; Findling RL; Calabrese JR
Psychopharmacol Bull; 2010; 43(4):5-21. PubMed ID: 21240149
[TBL] [Abstract][Full Text] [Related]
13. Maintenance treatment outcomes in older patients with bipolar I disorder.
Sajatovic M; Gyulai L; Calabrese JR; Thompson TR; Wilson BG; White R; Evoniuk G
Am J Geriatr Psychiatry; 2005 Apr; 13(4):305-11. PubMed ID: 15845756
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive treatment for mood stabilization of patients with bipolar I disorder treated with lamotrigine.
Spaulding T; Westlund R; Thomason C; White R; Dann R; Thompson T
CNS Spectr; 2006 Sep; 11(9):711-6; quiz 719. PubMed ID: 16946696
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study.
Findling RL; Chang K; Robb A; Foster VJ; Horrigan J; Krishen A; Wamil A; Kraus JE; DelBello M
J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1020-1031.e3. PubMed ID: 26598477
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder.
Zarzar MN; Graham J; Roberts J; Thompson T; Nanry K
MedGenMed; 2007 May; 9(2):41. PubMed ID: 17955096
[TBL] [Abstract][Full Text] [Related]
17. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression.
Suppes T; Marangell LB; Bernstein IH; Kelly DI; Fischer EG; Zboyan HA; Snow DE; Martinez M; Al Jurdi R; Shivakumar G; Sureddi S; Gonzalez R
J Affect Disord; 2008 Dec; 111(2-3):334-43. PubMed ID: 18358540
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
19. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
McElroy SL; Zarate CA; Cookson J; Suppes T; Huffman RF; Greene P; Ascher J
J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
